PC-Alarm Focus is a next-generation liquid biopsy capable of detecting prostate cancer risk from a urine sample. The test requires no puncture or invasive procedure. It is a fast, comfortable, and accurate solution that supports early detection!
Not every provider in cancer diagnostics has access to the advanced liquid biopsy solutions needed to deliver truly accurate and reliable results. We use diagnostic technologies and professional protocols that go far beyond traditional methods. As a specialised provider, we guarantee that our patients receive the highest level of professional support and clinical quality available..
Sample collection can be done at home
Does not carry bleeding or infection risks
Does not require tissue sampling or prostate massage
A positive result strongly indicates the presence of prostate cancer
It may be suitable for identifying a potential recurrence at an early stage.
With the at-home sample collection kit, there is no need for hospital visits or waiting rooms. You can enjoy the comfort and discretion of testing in your own home. The clear step-by-step guide makes sample collection easy, and returning the sample is quick and simple.
Even in the absence of symptoms, screening can be beneficial, as prostate cancer often develops silently. We always provide the results in a detailed, easy-to-understand PDF report that includes the interpretation of the findings and the recommended next steps. This report helps you and your physician make well-informed decisions.
Order nowWith a simple bodily fluid sample - such as urine - we are able to detect the presence of certain cancers. Compared to traditional tissue biopsies, this method is faster, safer and far more comfortable for patients, and it can be performed at a much earlier stage, when the tumour may still be inconclusive on imaging. The test identifies molecular signals that originate directly from the tumour, enabling more accurate and personalised diagnostics.
Learn more
Prostate cancer can develop silently for a long time, but with early detection it is far more treatable. PSA testing often provides uncertain results, as PSA levels can rise due to many other factors - such as inflammation or benign enlargement. In contrast, liquid biopsy examines molecular signals that directly indicate the presence of a tumor, making it far more specific. It can reduce unnecessary needle biopsies and overtreatment. Our method offers a more accurate, gentle, and reliable alternative for the timely detection of prostate cancer.
Sample collection can be performed in the comfort of your own home, but our partner institutions across the country are also available to assist you. The procedure is currently available only in Hungary.
Scientific Director, Molecular Biologist
The PC-Alarm Focus test can be ordered through our partner institutions, but we can also ship the sample collection kit anywhere nationwide upon request. After placing your order, you will receive the special collection tube along with the detailed protocol, which includes all necessary preparations and the correct procedure for collecting the sample.
The urine sample must be collected into the provided sampling tube according to the protocol. The tube must be tightly sealed and then stored at room temperature, protected from direct sunlight. Proper storage ensures sample stability and the reliability of the test.
The sample can be delivered to our laboratory through our partner institution, or, if preferred, returned using our courier service. During the analysis, we detect a molecular alteration originating from prostate cancer, helping support the possibility of establishing an early diagnosis.
The laboratory will complete the analysis within a maximum of 10 business days. You will receive the result in a detailed, easy-to-understand PDF report that includes an interpretation of the findings and recommendations for the necessary next steps.
PC-Alarm Focus is a modern urine-based diagnostic test that supports the early detection of prostate cancer. Due to the limitations of traditional PSA screening, many men undergo unnecessary biopsies, while some clinically significant cancers remain undiagnosed until a later stage. In contrast, PC-Alarm Focus is specifically designed to detect the TMPRSS2–ERG gene fusion, a molecular alteration strongly associated with prostate cancer. This genomic rearrangement does not occur in cancers of other organs, nor in inflammatory or benign conditions of the prostate, meaning its presence is a highly reliable indicator of malignancy.
The PC-Alarm Focus test is especially recommended for:
If you have an elevated PSA value (between 3–15 ng/ml)
If a clinical examination revealed an abnormal finding on prostate palpation
If a previous biopsy was negative but suspicion of a malignant lesion still persists.
Recommended for patients who are TMPRSS2–ERG fusion positive, to support early detection of recurrence.
If a biopsy cannot be performed at the moment for medical reasons but an immediate risk assessment is needed.
European Life Technologies Hungary is at the forefront of revolutionizing cancer diagnostics. As pioneers of liquid biopsy, we offer a painless and easily accessible alternative to invasive diagnostic procedures through advanced molecular technologies. Our proprietary platforms enable precise tumor identification and monitoring, providing exceptional accuracy in tumor profiling. Beyond shaping the field of liquid biopsy–based cancer diagnostics, we are building a professional community where everyone can openly share knowledge about cancer. Our goal is for European Life Technologies Hungary to become Europe’s leading scientific center in liquid biopsy research and innovation. We are committed to reshaping the future of personalized medicine so that people receive the support they need for the earliest possible detection, understanding, and monitoring of their disease.
Our partners are available at several locations across Hungary if you prefer to order our service in person.
View
“Nagyon köszönöm közreműködését betegségem javulása érdekében, már felvettem a kapcsolatot a Margit Medical Centerrel, várom telefonhivásukat.Nagylelküségükért, fáradozásukért nem tudok elégszer köszönetet mondani. ”
S. Eszter
BudapestPC-Alarm is a group of molecular diagnostic tests that support the early detection of prostate cancer based on genetic signals. It does not measure PSA; instead, it examines a specific gene fusion that is one of the most reliable molecular markers of aggressive prostate cancer.
If you would like to discuss PC-Alarm in more detail, fill out the form and we will contact you.
